" class="no-js "lang="en-US"> Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO - Medtech Alert
Saturday, February 04, 2023

Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the appointment of Sidonie Fabre, as chief financial officer. Sidonie took up her role on June 1.

Sidonie Fabre’s career history as CFO spans 15 years in the investment field, for listed and private companies. She was previously CFO at Crédit Agricole Régions Investissement. Sidonie started her career in finance as a sell-side analyst at CM-CIC Securities then as an asset manager at Covea Finance, before moving to become receivership director for a court-appointed administrator. From 2012 to 2016 Sidonie worked as a business development manager in the engineering industry. She holds a master’s degree in finance from Paris Dauphine University (Paris, France).

“I’m delighted to join AFB and its experienced team of investment experts. I’m truly fascinated by the biotech industry and its innovative startups. This is an exciting time for AFB and I’m very happy to help the company achieve its growth goals during 2021 and beyond,” said Sidonie Fabre.

As CFO at AFB, Sidonie will oversee all financial activities for the company. One of her priorities will be bringing a new vision for the company’s financial structure and providing a range of innovative solutions – which includes improving the reporting process to Limited Partners and legal authorities. She will also participate in promoting AFB to institutional investors.

“Sidonie is a multi-talented expert in business, financial and legal issues and we are thrilled to welcome her to the AFB team. Our continued growth requires stronger financial organization and management; Sidonie will help us achieve that as we are preparing to raise our second fund,” said Alain Huriez, MD, AFB co-founder and chairman. 

Companies In This Post

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more